Hepatic Synthesis Equipment & Supplies
1 equipment items found
Manufactured by:Darnitsa Group based inKyiv, UKRAINE
The primary site of action of rosuvastatin is the liver, the target organ for cholesterol lowering. Rosuvastatin increases the number of hepatic low-density lipoprotein (LDL) receptors on the cell surface, enhancing uptake and catabolism of LDL and it inhibits the hepatic synthesis of very low-density lipoproteins (VLDL), thereby reducing the ...